Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome
- PMID: 18178257
- DOI: 10.1016/j.jneuroim.2007.11.017
Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome
Abstract
In 176 patients with Guillain-Barré syndrome the subclass and cross-reactivity of serum IgG antibodies to motor gangliosides was related to preceding infections and clinical phenotypes. Two subgroups of patients were identified. Presence of only IgG1 antibodies was related to diarrhea, positive Campylobacter serology, cross-reactive antibodies to C. jejuni lipo-oligosaccharides and poor outcome. In contrast, having both IgG1 and IgG3 antibodies was related to upper respiratory tract infections, cross-reactive antibodies to Haemophilus influenzae lipo-oligosaccharides and better outcome. These findings support a model in which C. jejuni and H. influenzae infections induce two distinct patterns of cross-reactive antibodies with different clinical outcome.
Similar articles
-
Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.Neurology. 2005 May 10;64(9):1605-11. doi: 10.1212/01.WNL.0000160399.08456.7C. Neurology. 2005. PMID: 15883324
-
Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.J Neurol Sci. 2006 Jul 15;246(1-2):163-8. doi: 10.1016/j.jns.2006.02.010. J Neurol Sci. 2006. PMID: 16600306
-
[Campylobacter jejuni enteritis and Guillain-Barré syndrome].Rinsho Byori. 1999 Aug;47(8):713-8. Rinsho Byori. 1999. PMID: 10511801 Review. Japanese.
-
Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.Biochemistry. 2007 Jan 9;46(1):36-44. doi: 10.1021/bi062001v. Biochemistry. 2007. PMID: 17198373
-
Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.J Endotoxin Res. 2000;6(5):341-59. J Endotoxin Res. 2000. PMID: 11521055 Review.
Cited by
-
COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.Immun Inflamm Dis. 2023 May;11(5):e875. doi: 10.1002/iid3.875. Immun Inflamm Dis. 2023. PMID: 37249286 Free PMC article. Review.
-
Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey.Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(7):299-326. doi: 10.2183/pjab.88.299. Proc Jpn Acad Ser B Phys Biol Sci. 2012. PMID: 22850724 Free PMC article. Review.
-
Guillain-Barre syndrome presenting with sensory disturbance following a herpes virus infection: a case report.J Med Case Rep. 2011 Dec 4;5:563. doi: 10.1186/1752-1947-5-563. J Med Case Rep. 2011. PMID: 22136568 Free PMC article.
-
Immunotherapy of Guillain-Barré syndrome.Hum Vaccin Immunother. 2018;14(11):2568-2579. doi: 10.1080/21645515.2018.1493415. Epub 2018 Jul 12. Hum Vaccin Immunother. 2018. PMID: 29953326 Free PMC article. Review.
-
Detection and genotyping of Campylobacter jejuni and Campylobacter coli by use of DNA oligonucleotide arrays.Mol Biotechnol. 2013 Feb;53(2):182-8. doi: 10.1007/s12033-012-9512-0. Mol Biotechnol. 2013. PMID: 22354794
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical